AI + live data · analyst records & stock signals
KoalCheckKoalCheck
LeaderboardMembershipBuilder
Connect your AI client via MCP
Endpoint (paste into an MCP client — anonymous, free, no key)
https://mcp.koalcheck.com/mcp
Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

CapabilitiesUser guide
← @shufen46250836

$ABBV

BULLISH2025-11-19
Price around the call
↑ 2025-11-19
By horizon✗ miss-5.9%
1d
✓ +2.0%
5d
✗ -5.5%
21d
✗ -5.9%
Original post
shu fen · 2025-11-19

今天的A股指数在50日均线上方震荡,不过国家队护盘意图比较明显,银行板块全天强势,但可惜只有国家队的资金在买,市场选择继续观望, 两市交易量只有1.7万亿了,和昨天相比少了2000多亿,说明资金不愿意进场,还是很谨慎,这已经不错了,看看隔壁的港股,俨然成了爹不疼妈不爱的弃子。 对于恒生科技来说,全村的希望在阿里巴巴了,阿里巴巴交出一份好的财报,恒生科技就有希望,百度的财报真的太烂了,不配享有BAT这个并列。 昨晚美股三大指数继续下跌,这已经是连续第四天了,生物医疗板块再次领涨,现在生物医药已经成为了美股的香饽饽了, 那生物医药领域还能不能上车呢?虽然目前XBI已经盈利10+了,但我认为如果以季度为交易周期,生物医药的行情刚刚开始而已 至于我持仓的医药股,完全没有必要参与,一是涨幅已经很多了,二是容易归零,就XBI就很好 黄金、白银涨势也比较好,这些防御性质的资产涨的好,意味着科技股在挨打,科技股能否反弹在于英伟达的财报,12月的降息预期的提升,再熬一熬。 昨天看到 @MSX_CN 上了两个医药股, $MRK 和 $ABBV 这两个医药股的话, $ABBV 相对远期市盈率只有16.1倍,低于医疗板块平均的17.9倍,估值优势比较明显,对医药股感兴趣的可以关注一下, 刚发现还有积分M豆了,不过所有的M豆都是交易得到的,压根没有什么战队,那求个战队的组局吧 链接传送门:https://t.co/2MzPcwrNOj

View on X ↗
KoalCheckKoalCheck

Honest, price-verified track records for US-stock callers on X.

© 2026 KoalCheck. All rights reserved.

ProductLeaderboardCall streamHot tickersAI assistantMembershipBuilderMCP & API access
LegalTerms of ServicePrivacy PolicyDisclaimer
ContactX · @koalcheck[email protected]

KoalCheck is an information-aggregation and research tool — not investment advice. Data may be delayed or inaccurate. Investing involves risk; decide carefully.

Tweet content © its original authors. Data sources: public X content · SEC EDGAR · FINRA. Methodology and site design © KoalCheck.